Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc.
12/12/2025 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2025 5:00 P.M. |
| Form: | S-1 | ||||||
|
|||||||
Aspire Biopharma Holdings Inc. published this content on December 12, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 15, 2025 at 11:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]